News Releases | Lucira Health, Inc

Year

09 Apr '21

LUCIRA COVID-19 Test Kit Identifies Viral Variants

LUCIRA COVID-19 All-In-One Test Kit reactive to at least 99.9% of all known COVID-19 virus strains EMERYVILLE, Calif.--( BUSINESS WIRE )--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious

11 Feb '21

U.S. Physicians Can Now Order Lucira Health Self-Administered, Lab Quality, COVID-19 Molecular Test for Home or Office

--- Lab-quality results in 30 minutes or less --- EMERYVILLE, Calif.--( BUSINESS WIRE )--Lucira Health, Inc. (Nasdaq: LHDX), today announced that U.S. physicians and healthcare providers can now order Lucira COVID-19 All-In-One Test Kits online from lucirahealth.com . This U.S.

09 Feb '21

Lucira Health Announces Closing of its Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

EMERYVILLE, Calif.--( BUSINESS WIRE )--Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced the closing of its upsized initial public offering

04 Feb '21

Lucira Health Announces Pricing of Its Upsized Initial Public Offering

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 11 - 14 of 14